Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 03, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 03, 2026
STIM1 deletion in regulatory T cells restores redox balance and protects against hypertension-induced cardiovascular complications.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: August 18, 2025
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2025.1.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 17, 2025
Endothelial CHOP as a central mechanism in renovascular hypertension-induced vascular endothelial dysfunction and cardiac fibrosis.
Journal: Cellular and molecular life sciences : CMLS
Published: January 15, 2025
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 12, 2024
Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 26, 2024
Unveiling the vulnerability of C57BL/6J female mice to HFpEF and its related complications.
Journal: Journal of molecular and cellular cardiology plus
Published: March 29, 2024
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 28, 2024
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 28, 2024
Systemic Therapy for Melanoma: ASCO Guideline Update.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 14, 2023
Plasmacytoid dendritic cells contribute to vascular endothelial dysfunction in type 2 diabetes.
Journal: Frontiers in cardiovascular medicine
Published: May 15, 2023
Last Updated: 09/26/2026